[go: up one dir, main page]

DE69630918D1 - Matrix für Iontophorese - Google Patents

Matrix für Iontophorese

Info

Publication number
DE69630918D1
DE69630918D1 DE69630918T DE69630918T DE69630918D1 DE 69630918 D1 DE69630918 D1 DE 69630918D1 DE 69630918 T DE69630918 T DE 69630918T DE 69630918 T DE69630918 T DE 69630918T DE 69630918 D1 DE69630918 D1 DE 69630918D1
Authority
DE
Germany
Prior art keywords
drug
humectant
weight
iontophoresis
proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630918T
Other languages
English (en)
Other versions
DE69630918T2 (de
Inventor
Yasuyuki Suzuki
Katsumi Iga
Yukihiro Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69630918D1 publication Critical patent/DE69630918D1/de
Application granted granted Critical
Publication of DE69630918T2 publication Critical patent/DE69630918T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE69630918T 1995-06-09 1996-06-04 Matrix für Iontophorese Expired - Fee Related DE69630918T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14298395 1995-06-09
JP14298395 1995-06-09
JP20190295 1995-08-08
JP20190295 1995-08-08

Publications (2)

Publication Number Publication Date
DE69630918D1 true DE69630918D1 (de) 2004-01-15
DE69630918T2 DE69630918T2 (de) 2004-10-28

Family

ID=26474826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630918T Expired - Fee Related DE69630918T2 (de) 1995-06-09 1996-06-04 Matrix für Iontophorese

Country Status (5)

Country Link
US (2) US5993848A (de)
EP (1) EP0747092B1 (de)
AT (1) ATE255450T1 (de)
CA (1) CA2178445A1 (de)
DE (1) DE69630918T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2208332A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Drug administration composition for iontophoresis
CA2208336A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. A device structure for iontophoresis
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
US6322550B2 (en) 1998-04-14 2001-11-27 Hisamitsu Pharmaceutical Co., Inc. Method for transdermal administration of GP IIb/IIIa antagonist
EP1222930B1 (de) * 1999-10-14 2006-11-02 Pola Chemical Industries Inc. Zusammensetzungen für die elektroporation
JP4868679B2 (ja) 1999-10-14 2012-02-01 ポーラ化成工業株式会社 エレクトロポーレーション用の組成物
US7498297B2 (en) * 2000-07-18 2009-03-03 Cornell Research Foundation Medicinal uses of mu-opioid receptor agonists
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
HUE027110T2 (en) * 2003-02-04 2016-08-29 Cornell Res Foundation Inc Use of an aromatic cationic peptide
AU2004252419B2 (en) 2003-05-01 2010-02-18 Cornell Research Foundation, Inc Method and carrier complexes for delivering molecules to cells
RU2376028C2 (ru) 2004-01-23 2009-12-20 Корнелл Рисеч Фаундейшн, Инк. Способ уменьшения окислительного повреждения (варианты)
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
WO2006131931A2 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
KR101621493B1 (ko) * 2005-09-16 2016-05-16 코넬 리서치 화운데이션,인크. Ｃｄ36 발현을 감소시키는 방법
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
CA2704164A1 (en) * 2007-10-29 2009-05-07 Transpharma Medical Ltd. Vertical patch drying
WO2009100363A2 (en) 2008-02-07 2009-08-13 Cornell University Methods for preventing or treating insulin resistance
WO2009108695A2 (en) 2008-02-26 2009-09-03 Cornell University Methods for prevention and treatment of acute renal injury
AU2009255619A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
WO2010120431A2 (en) 2009-03-20 2010-10-21 The General Hospital Corporation D/B/A Massachusetts General Hospital Methods for the prevention and treatment of burn injuries and secondary complications
WO2011019809A1 (en) * 2009-08-12 2011-02-17 Cornell University Methods for preventing or treating metabolic syndrome
EP2990049A1 (de) 2009-08-24 2016-03-02 Stealth Peptides International, Inc. Verfahren und zusammensetzungen zur prävention oder behandlung ophthalmischer leiden
EP3120860B1 (de) 2009-10-05 2019-06-26 Cornell University Verfahren zur prävention und behandlung von herzinsuffizienz
US9362378B2 (en) 2011-10-28 2016-06-07 Indian Institute Of Technology Madras Piezoelectric devices and methods for their preparation and use
CA2868534A1 (en) 2012-03-27 2013-10-03 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
NZ701949A (en) 2012-05-18 2016-07-29 Otago Innovation Ltd Combination treatments and compositions for wound healing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5612347A (en) * 1988-03-28 1997-03-18 Janssen Pharmaceutica N.V. Agents for preserving or restoring the soundness of the skin
DE69026323T2 (de) * 1989-02-06 1996-10-24 Hisamitsu Pharmaceutical Co Schnittstelle für iontophorese
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
EP0612253A4 (de) * 1991-11-12 1995-08-09 Nepera Inc Anklebenok hydrogele mit verlängerter lebensdauer und verfahren zu ihrer herstellung.
ES2120477T3 (es) * 1992-01-21 1998-11-01 Macrochem Corp Administracion iontoforetica de medicamentos perfeccionada.
DE69326461T2 (de) * 1992-06-11 2000-05-04 Theratech Inc., Salt Lake City Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
AU4585493A (en) * 1992-07-23 1994-02-14 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and drug composition prepared therefrom
ATE211655T1 (de) * 1993-09-22 2002-01-15 Hisamitsu Pharmaceutical Co Iontophoresematrix
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

Also Published As

Publication number Publication date
US6248349B1 (en) 2001-06-19
EP0747092A3 (de) 1998-04-08
CA2178445A1 (en) 1996-12-10
US5993848A (en) 1999-11-30
EP0747092A2 (de) 1996-12-11
EP0747092B1 (de) 2003-12-03
DE69630918T2 (de) 2004-10-28
ATE255450T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
ATE255450T1 (de) Matrix für iontophorese
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ATE196092T1 (de) Wachstumshormon-enthaltendeproteinformulierung
ATE204467T1 (de) Orale darreichungsform
CA2275890A1 (en) Stable liquid interferon formulations
ATE442851T1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
PT1017413E (pt) Formulacoes liquidas de interferao (beta)
DE69417397D1 (de) Lösung, die igf-1 enthält
US6399566B1 (en) Topical preparation for introducing insulin in living organisms
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
Shen et al. Cell Reproduction
OA12322A (en) Topical pharmaceutical preparation.
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
CA2153787A1 (en) Solution containing igf-1
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee